In January 2020, EuropaBio finalised a vision document with key recommendations for stimulating a successful life sciences and biotechnology ecosystem in the EU.
As the Association representing the European biotechnology industry, EuropaBio is fully committed to the development of a legislative environment which facilitates the creation of EU jobs and growth as well as new solutions to healthcare challenges.
EuropaBio notes the adoption by the European Parliament of the report on EU options for improving patient access to medicines on 2 March 2017, in Brussels.